Literature DB >> 17269789

Optimization of protein fusion partner length for maximizing in vitro translation of peptides.

Christopher R Loose1, Robert S Langer, Gregory N Stephanopoulos.   

Abstract

Using protein fusion partners for in vitro translation may increase solubility, assist in purification, or allow detection of small proteins and peptides. Here we show that the molar yield of peptide in a batch reaction may be maximized by optimizing the length of the translated product, which is composed of the fusion partner plus the peptide. Using truncated versions of GFP as a series of fusion partners, the molar yield increased approximately 3-fold as the length of the translated product was reduced from 250 to 100 amino acids. When the translated product was shortened below roughly 100 amino acids, molar yield fell as a result of proteolysis. This trend was verified using two fusion partners with different amino acid sequences. Furthermore, protease inhibitors were used to confirm that proteases were responsible for limiting accumulation of peptides below the optimal length.

Mesh:

Substances:

Year:  2007        PMID: 17269789     DOI: 10.1021/bp060277o

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  4 in total

Review 1.  Cell-free synthetic biology: thinking outside the cell.

Authors:  C Eric Hodgman; Michael C Jewett
Journal:  Metab Eng       Date:  2011-09-18       Impact factor: 9.783

2.  Classification and function of small open reading frames.

Authors:  Juan-Pablo Couso; Pedro Patraquim
Journal:  Nat Rev Mol Cell Biol       Date:  2017-07-12       Impact factor: 94.444

3.  Developmental regulation of canonical and small ORF translation from mRNAs.

Authors:  Pedro Patraquim; Muhammad Ali Shahzad Mumtaz; José Ignacio Pueyo; Julie Louise Aspden; Juan-Pablo Couso
Journal:  Genome Biol       Date:  2020-05-29       Impact factor: 13.583

4.  Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation system.

Authors:  Yue Wu; Zhenling Cui; Yen-Hua Huang; Simon J de Veer; Andrey V Aralov; Zhong Guo; Shayli V Moradi; Alexandra O Hinton; Jennifer R Deuis; Shaodong Guo; Kai-En Chen; Brett M Collins; Irina Vetter; Volker Herzig; Alun Jones; Matthew A Cooper; Glenn F King; David J Craik; Kirill Alexandrov; Sergey Mureev
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.